High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma
出版年份 2015 全文链接
标题
High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma
作者
关键词
Multiple myeloma, Plasma cell, Endoplasmic reticulum, Chaperone, grp94, gp96, Biomarker
出版物
Journal of Hematology & Oncology
Volume 8, Issue 1, Pages 77
出版商
Springer Nature
发表日期
2015-06-27
DOI
10.1186/s13045-015-0177-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phase I Study of 30-Minute Infusion of Carfilzomib As Single Agent or in Combination With Low-Dose Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
- (2015) Kyriakos P. Papadopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma
- (2015) Arnold Bolomsky et al. Journal of Hematology & Oncology
- Structure–Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94
- (2015) Hardik J. Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
- (2014) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myélome
- (2014) Murielle Roussel et al. JOURNAL OF CLINICAL ONCOLOGY
- Aprepitant, Granisetron, and Dexamethasone for Prevention of Chemotherapy-Induced Nausea and Vomiting After High-Dose Melphalan in Autologous Transplantation for Multiple Myeloma: Results of a Randomized, Placebo-Controlled Phase III Trial
- (2014) Thomas Schmitt et al. JOURNAL OF CLINICAL ONCOLOGY
- Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study
- (2014) M Garcia et al. Journal of Hematology & Oncology
- Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization
- (2014) Kunkun Han et al. Journal of Hematology & Oncology
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma
- (2014) Xiaoyan Qu et al. MEDICAL ONCOLOGY
- Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma
- (2013) Kate Vandyke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma
- (2013) Y. Hua et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Multiple Myeloma
- (2013) N. C. Munshi et al. CLINICAL CANCER RESEARCH
- Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
- (2013) Wenli Zheng et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
- (2013) Mohamed A Kharfan-Dabaja et al. Journal of Hematology & Oncology
- Fact or fiction - identifying the elusive multiple myeloma stem cell
- (2013) Joshua Kellner et al. Journal of Hematology & Oncology
- Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
- (2013) Cornel Phillip et al. Journal of Hematology & Oncology
- A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial
- (2013) Jian Hou et al. Journal of Hematology & Oncology
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2
- (2013) Pallav D Patel et al. Nature Chemical Biology
- Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway
- (2013) B. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Future of Drug Development and Therapy in Myeloma
- (2013) Sagar Lonial et al. SEMINARS IN ONCOLOGY
- How should we treat newly diagnosed multiple myeloma patients?
- (2013) M.-V. Mateos et al. Hematology-American Society of Hematology Education Program
- The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis
- (2013) Shai White-Gilbertson et al. Frontiers in Genetics
- Preventive strategies in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
- (2012) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain
- (2012) Shuang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
- (2012) H Ludwig et al. LEUKEMIA
- Redefining myeloma
- (2012) S. Vincent Rajkumar et al. Nature Reviews Clinical Oncology
- Murine but Not Human Basophil Undergoes Cell-Specific Proteolysis of a Major Endoplasmic Reticulum Chaperone
- (2012) Bei Liu et al. PLoS One
- Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
- (2012) Jiri Minarik et al. TheScientificWorldJOURNAL
- Approach to the treatment of multiple myeloma: a clash of philosophies
- (2011) S. V. Rajkumar et al. BLOOD
- Unfolded protein response in cancer: the Physician's perspective
- (2011) Xuemei Li et al. Journal of Hematology & Oncology
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- Treatment of multiple myeloma
- (2011) S. Vincent Rajkumar Nature Reviews Clinical Oncology
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improvement in Survival of Older Adults with Multiple Myeloma: Results of an Updated Period Analysis of SEER Data
- (2011) D. Pulte et al. ONCOLOGIST
- AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
- (2011) H Yao et al. Blood Cancer Journal
- XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
- (2010) T. Bagratuni et al. BLOOD
- Multiple Myeloma Precursor Disease
- (2010) Ola Landgren et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
- (2010) Johann Micallef et al. Journal of Hematology & Oncology
- Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone
- (2010) Bei Liu et al. Nature Communications
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis
- (2009) M. Staron et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- -Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model
- (2009) E. Ashihara et al. CLINICAL CANCER RESEARCH
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started